- Home
- IMTE vs CRIS Comparison
IMTE vs CRIS Comparison
Compare IMTE & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMTE | CRIS |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 2.0M |
| IPO Year | 2016 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IMTE | CRIS |
|---|---|---|
| Price | $0.49 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 122.8K | ★ 160.7K |
| Earning Date | 10-22-2024 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.40 | $0.34 |
| 52 Week High | $1.34 | $3,360.00 |
Technical Indicators
Market Signals| Indicator | IMTE | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 19.38 |
| Support Level | $0.43 | $0.34 |
| Resistance Level | $0.54 | $5.50 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | 0.00 | 1.34 |
| Stochastic Oscillator | 76.22 | 6.85 |
Price Performance
Historical ComparisonAbout IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is mainly engaged in the business of manufacture and sale of nano-coated plates for filters, the manufacture and sale of electronic glass, Halal certification and distribution of Halal products, and new energy products and services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.